Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea · Delayed Price · Currency is KRW 17,800
-220 (-1.22%)
Aug 21, 2026, 3:30 PM KST
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 218.19 billion as of August 21, 2026. Its market cap has decreased by -7.82% in one year.
Market Cap
218.19B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
10.30
Stock Price
17,800.00
ChartMarket Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 218.19B, an increase of 649.28%. That is a compound annual growth rate of 6.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 218.19B | -9.87% |
| Dec 30, 2025 | 242.09B | 9.24% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humedix | 272.97B |
| Suheung | 262.81B |
| Korea United Pharm | 259.50B |
| Yungjin Pharm. | 222.95B |
| Boditech Med | 212.61B |
| REYON Pharmaceutical | 185.98B |
| Chong Kun Dang Holdings | 185.66B |
| Whan In Pharm | 184.84B |